Physician

Arley Gustavo Jaramillo, M.D.

According to 2025 Medicare claims, Arley Jaramillo, M.D. (NPI: 1699955450) practices ophthalmology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is 4 YOUR EYES, LLC (NPI: 1437329034; TIN: 721416649) and primary practice location at 70458-2087. Jaramillo is affiliated with the Imperium Clinical Partners (ACO ID: A4945), participating under the MSSP model.

Jaramillo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 519 traditional Medicare patients, billed 8,454 HCPCS/CPT codes, and received $609,576 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 2,571 prescription claims across 490 beneficiaries totaling $144,486 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 28 records totaling $672. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $402,132 to $609,576. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$305K$610K2015 Medicare payment: $402,132 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $360,854 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $308,984 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $295,893 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $432,613 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $471,674 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $488,008 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $513,610 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $551,465 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $609,576 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156743,720$402,132
20167133,490$360,854
20176493,546$308,984
20186173,524$295,893
20196654,273$432,613
20205434,238$471,674
20215053,719$488,008
20224843,412$513,610
20235146,966$551,465
20245198,454$609,576

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$194K$389K2015 Drug cost: $55,401 (USD; Tot_Drug_Cst)2016 Drug cost: $85,252 (USD; Tot_Drug_Cst)2017 Drug cost: $76,574 (USD; Tot_Drug_Cst)2018 Drug cost: $88,058 (USD; Tot_Drug_Cst)2019 Drug cost: $388,706 (USD; Tot_Drug_Cst)2020 Drug cost: $161,114 (USD; Tot_Drug_Cst)2021 Drug cost: $147,081 (USD; Tot_Drug_Cst)2022 Drug cost: $154,002 (USD; Tot_Drug_Cst)2023 Drug cost: $156,183 (USD; Tot_Drug_Cst)2024 Drug cost: $144,486 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015193888$55,401
20162531,189$85,252
20172471,236$76,574
20182771,351$88,058
20193992,000$388,706
20204062,126$161,114
20213781,950$147,081
20224322,193$154,002
20234672,337$156,183
20244902,571$144,486

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system7676$85
92014Established patient complete exam of visual system408973$79
67028Injection of drug into eye63394$78
92134Imaging of retina74387$27
92250Photography of the retina430689$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine602,010$35,088
LumiganBimatoprost743,088$33,013
Brimonidine TartrateBrimonidine Tartrate1919,744$13,966
SimbrinzaBrinzolamide/Brimonidine Tart421,630$12,550
LatanoprostLatanoprost1,01447,470$6,909

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.28$672Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Arley Gustavo Jaramillo, M.D.?

Tedicare shows public-source Medicare data for Arley Gustavo Jaramillo, M.D. (NPI 1699955450), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arley Gustavo Jaramillo, M.D. have ACO affiliation data?

Arley Gustavo Jaramillo, M.D. is shown with ACO affiliation data for Imperium Clinical Partners (MSSP, ACO ID A4945).

What billing organization is linked to Arley Gustavo Jaramillo, M.D.?

Arley Gustavo Jaramillo, M.D. is linked to 4 YOUR EYES, LLC (billing NPI 1437329034) in the available physician profile data.

Does Arley Gustavo Jaramillo, M.D. have Open Payments data?

Arley Gustavo Jaramillo, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.